Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Nat Immunol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    May 2022
  1. LUSTIG Y, Gonen T, Meltzer L, Gilboa M, et al
    Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
    Nat Immunol. 2022 May 9. pii: 10.1038/s41590-022-01212.
    PubMed     Abstract available


    March 2022

  2. IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01177.
    PubMed    


  3. KOBIYAMA K, Ishii KJ
    Making innate sense of mRNA vaccine adjuvanticity.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01168.
    PubMed    


  4. TAHTINEN S, Tong AJ, Himmels P, Oh J, et al
    IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
    Nat Immunol. 2022 Mar 24. pii: 10.1038/s41590-022-01160.
    PubMed     Abstract available


  5. LI C, Lee A, Grigoryan L, Arunachalam PS, et al
    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
    Nat Immunol. 2022 Mar 14. pii: 10.1038/s41590-022-01163.
    PubMed     Abstract available


  6. MARTINEZ DR, Ooi EE
    A potential silver lining of delaying the second dose.
    Nat Immunol. 2022;23:349-351.
    PubMed    


    February 2022
  7. TOMALKA JA, Suthar MS, Deeks SG, Sekaly RP, et al
    Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Nat Immunol. 2022 Feb 24. pii: 10.1038/s41590-022-01130.
    PubMed     Abstract available


  8. HALL VG, Ferreira VH, Wood H, Ierullo M, et al
    Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
    Nat Immunol. 2022 Feb 3. pii: 10.1038/s41590-021-01126.
    PubMed     Abstract available


    January 2022
  9. EGWANG TG, Owalla TJ, Kemigisha M
    COVID-19 vaccine trials must include helminth-infected cohorts.
    Nat Immunol. 2022 Jan 24. pii: 10.1038/s41590-021-01116.
    PubMed    


  10. DOWELL AC, Butler MS, Jinks E, Tut G, et al
    Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Nat Immunol. 2022;23:40-49.
    PubMed     Abstract available


    December 2021
  11. BERNARD NJ
    Vaccine thrombosis.
    Nat Immunol. 2021 Dec 22. pii: 10.1038/s41590-021-01111.
    PubMed    


    November 2021
  12. BREWER RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al
    BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Nat Immunol. 2021 Nov 30. pii: 10.1038/s41590-021-01088.
    PubMed     Abstract available


  13. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    PubMed     Abstract available



  14. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.
    PubMed    


    October 2021
  15. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    PubMed     Abstract available


    September 2021
  16. TOMALKA JA, Pelletier AN, Fourati S, Latif MB, et al
    The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
    Nat Immunol. 2021 Sep 23. pii: 10.1038/s41590-021-01026.
    PubMed     Abstract available


  17. NAKAYA HI
    Hidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunity.
    Nat Immunol. 2021 Sep 23. pii: 10.1038/s41590-021-01018.
    PubMed    


  18. WOLYNN T, Hermann C
    Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Nat Immunol. 2021;22:1068-1070.
    PubMed    


  19. FEHERVARI Z
    Intranasal vaccination.
    Nat Immunol. 2021;22:1071.
    PubMed    


  20. ALSUWAIDI AR, Al Hosani FI, ElGhazali G, Al-Ramadi BK, et al
    The COVID-19 response in the United Arab Emirates: challenges and opportunities.
    Nat Immunol. 2021;22:1066-1067.
    PubMed    


  21. YAO Y, Chen Z, Zhang H, Chen C, et al
    Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.
    Nat Immunol. 2021;22:1127-1139.
    PubMed     Abstract available


    July 2021
  22. CUPOVIC J, Ring SS, Onder L, Colston JM, et al
    Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00969.
    PubMed     Abstract available


  23. DAI L, Xu K, Li J, Huang Q, et al
    Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00966.
    PubMed     Abstract available


  24. MUKHTAR MM, Khogali M
    The accelerating COVID-19 epidemic in Sudan.
    Nat Immunol. 2021;22:797-798.
    PubMed    


    April 2021
  25. CHEN SC
    Taiwan's experience in fighting COVID-19.
    Nat Immunol. 2021;22:393-394.
    PubMed    


    March 2021
  26. GEOGHEGAN JL, Moreland NJ, Le Gros G, Ussher JE, et al
    New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Nat Immunol. 2021;22:262-263.
    PubMed    


  27. MADKAIKAR M, Gupta N, Yadav RM, Bargir UA, et al
    India's crusade against COVID-19.
    Nat Immunol. 2021;22:258-259.
    PubMed    



  28. Coping with COVID.
    Nat Immunol. 2021;22:255.
    PubMed    


    January 2021
  29. NELDE A, Bilich T, Heitmann JS, Maringer Y, et al
    SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nat Immunol. 2021;22:74-85.
    PubMed     Abstract available



  30. Challenges for the Biden presidency.
    Nat Immunol. 2021;22:1.
    PubMed    


  31. DIVANGAHI M, Aaby P, Khader SA, Barreiro LB, et al
    Trained immunity, tolerance, priming and differentiation: distinct immunological processes.
    Nat Immunol. 2021;22:2-6.
    PubMed    


    November 2020
  32. BAHAROM F, Ramirez-Valdez RA, Tobin KKS, Yamane H, et al
    Intravenous nanoparticle vaccination generates stem-like TCF1(+) neoantigen-specific CD8(+) T cells.
    Nat Immunol. 2020 Nov 2. pii: 10.1038/s41590-020-00810.
    PubMed     Abstract available


  33. PENG Y, Mentzer AJ, Liu G, Yao X, et al
    Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
    Nat Immunol. 2020;21:1336-1345.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: